Your browser doesn't support javascript.
loading
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
Hall, MacLean S; Teer, Jamie K; Yu, Xiaoqing; Branthoover, Holly; Snedal, Sebastian; Rodriguez-Valentin, Madeline; Nagle, Luz; Scott, Ellen; Schachner, Ben; Innamarato, Patrick; Hall, Amy M; Blauvelt, Jamie; Rich, Carolyn J; Richards, Allison D; Ceccarelli, Jake; Langer, T J; Yoder, Sean J; Beatty, Matthew S; Cox, Cheryl A; Messina, Jane L; Abate-Daga, Daniel; Mule, James J; Mullinax, John E; Sarnaik, Amod A; Pilon-Thomas, Shari.
Affiliation
  • Hall MS; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Teer JK; Cancer Biology PhD Program, University of South Florida, Tampa, Florida, USA.
  • Yu X; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Branthoover H; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Snedal S; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Rodriguez-Valentin M; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Nagle L; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Scott E; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Schachner B; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Innamarato P; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Hall AM; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Blauvelt J; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Rich CJ; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Richards AD; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Ceccarelli J; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Langer TJ; Turnstone Biologics, Inc, San Diego, California, USA.
  • Yoder SJ; Turnstone Biologics, Inc, San Diego, California, USA.
  • Beatty MS; Molecular Genomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Cox CA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Messina JL; Cell Therapies Core Facility, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Abate-Daga D; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Mule JJ; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Mullinax JE; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Sarnaik AA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Pilon-Thomas S; Department of Sarcoma, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
J Immunother Cancer ; 11(10)2023 10.
Article in En | MEDLINE | ID: mdl-37802604
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocytes, Tumor-Infiltrating / Melanoma Type of study: Guideline Limits: Humans Language: En Journal: J Immunother Cancer Year: 2023 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocytes, Tumor-Infiltrating / Melanoma Type of study: Guideline Limits: Humans Language: En Journal: J Immunother Cancer Year: 2023 Document type: Article Affiliation country: Estados Unidos